Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening

BACKGROUND: Newborn screening (NBS) for sickle cell disease incidentally identifies heterozygous carriers of hemoglobinopathy mutations. In Ontario, Canada, these carrier results are not routinely disclosed, presenting an opportunity to investigate the potential health implications of carrier status...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Pediatr
Asıl Yazarlar: Khangura, Sara D., Potter, Beth K., Davies, Christine, Ducharme, Robin, Bota, A. Brianne, Hawken, Steven, Wilson, Kumanan, Karaceper, Maria D., Klaassen, Robert J., Little, Julian, Simpson, Ewurabena, Chakraborty, Pranesh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247172/
https://ncbi.nlm.nih.gov/pubmed/34210267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-021-02751-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller